Rick Matthews: Venous Thromboembolism Treatment Isn’t the Same For Everyone
Rick Matthews, Sr. Vascular Consultant at Argon Medical Devices, Inc. and Radiology Instructor at Pima Medical Institute, shared a post on LinkedIn:
”VTE treatment isn’t one-size-fits-all.
When evaluating a patient with DVT, the decision to intervene should start with the fundamentals: anatomy, chronicity, symptom burden, and patient risk.
Technology continues to evolve, but good clinical decision-making still starts with understanding the patient and choosing the right strategy for the individual situation.
The goal isn’t simply to remove clot — it’s to make the right treatment decision for the right patient.
What factors weigh most heavily in your decision-making when evaluating VTE patients?”
Find more posts featuring Rick Matthews on Hemostasis Today.
-
Sep 7, 2026, 15:20Andrew Jones: Platelet Count Is Only One Dimension of Hemostatic Function
-
Sep 7, 2026, 15:10Can Novel Anticoagulants Reduce Thrombosis Without Increasing Bleeding – JTH
-
Sep 7, 2026, 15:09Kashis Gupta: Excited to Share My AI/ML Project – Anemia Fusion Net!
-
Sep 7, 2026, 15:08Adam Urato: The Platelet Paradox of SSRIs
-
Sep 7, 2026, 15:00Haroon Gul Khan: Why Critical Reading Matters in Medical Education
-
Sep 7, 2026, 14:59Ahmed Mahmoud: Vitamin B12 Deficiency Can Present Far Beyond Fatigue and Macrocytic Anemia
-
Sep 7, 2026, 14:49Abid Husain: Tirzepatide Drives Broad Improvements in Cardiovascular Risk Biomarkers
-
Sep 7, 2026, 14:46Shabnam Arsiwala: Did You Know there are Multiple Types of Sickle Cell Disease?
-
Sep 7, 2026, 14:46Ahmed Bennis: Angiotensin II and Platelet PAR4 Activation in Hypertension